Menu
GWAS Study

Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02).

Limou S, Le Clerc S, Coulonges C et al.

19115949 PubMed ID
GWAS Study Type
1713 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LS
Limou S
LC
Le Clerc S
CC
Coulonges C
CW
Carpentier W
DC
Dina C
DO
Delaneau O
LT
Labib T
TL
Taing L
SR
Sladek R
DC
Deveau C
RR
Ratsimandresy R
MM
Montes M
SJ
Spadoni JL
LJ
Lelièvre JD
LY
Lévy Y
TA
Therwath A
SF
Schächter F
MF
Matsuda F
GI
Gut I
FP
Froguel P
DJ
Delfraissy JF
HS
Hercberg S
ZJ
Zagury JF
Chapter II

Abstract

Summary of the research findings

To elucidate the genetic factors predisposing to AIDS progression, we analyzed a unique cohort of 275 human immunodeficiency virus (HIV) type 1-seropositive nonprogressor patients in relation to a control group of 1352 seronegative individuals in a genomewide association study (GWAS). The strongest association was obtained for HCP5 rs2395029 (P=6.79x10(-10); odds ratio, 3.47) and was possibly linked to an effect of sex. Interestingly, this single-nucleotide polymorphism (SNP) was in high linkage disequilibrium with HLA-B, MICB, TNF, and several other HLA locus SNPs and haplotypes. A meta-analysis of our genomic data combined with data from the previously conducted Euro-CHAVI (Center for HIV/AIDS Vaccine Immunology) GWAS confirmed the HCP5 signal (P=3.02x10(-19)) and identified several new associations, all of them involving HLA genes: MICB, TNF, RDBP, BAT1-5, PSORS1C1, and HLA-C. Finally, stratification by HCP5 rs2395029 genotypes emphasized an independent role for ZNRD1, also in the HLA locus, and this finding was confirmed by experimental data. The present study, the first GWAS of HIV-1 nonprogressors, underscores the potential for some HLA genes to control disease progression soon after infection.

275 European ancestry seropositive non-progressors, 86 European ancestry seropositive rapid progressors, 1,352 European ancestry seronegative controls

Chapter III

Study Statistics

Key metrics and study information

1713
Total Participants
GWAS
Study Type
Yes
Replicated
(see Fellay 2007)
Replication Participants
European
Ancestry
France
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.